Vertex Pharmaceuticals
VRTX
#201
Rank
NZ$198.83 B
Marketcap
NZ$783.40
Share price
-1.47%
Change (1 day)
6.87%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$12.33 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are NZ$12.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$12.04 B10.95%
2024-12-31NZ$10.85 B33.34%
2023-12-31NZ$8.14 B21.99%
2022-12-31NZ$6.67 B36.82%
2021-12-31NZ$4.87 B14.86%
2020-12-31NZ$4.24 B28.1%
2019-12-31NZ$3.31 B22.84%
2018-12-31NZ$2.69 B27.49%
2017-12-31NZ$2.11 B-5.9%
2016-12-31NZ$2.25 B9.61%
2015-12-31NZ$2.05 B29.87%
2014-12-31NZ$1.58 B34.94%
2013-12-31NZ$1.17 B-38.36%
2012-12-31NZ$1.90 B16.26%
2011-12-31NZ$1.63 B3.25%
2010-12-31NZ$1.58 B33.85%
2009-12-31NZ$1.18 B-7.44%
2008-12-31NZ$1.27 B196.47%
2007-12-31NZ$0.43 B-26.94%
2006-12-31NZ$0.58 B30.16%
2005-12-31NZ$0.45 B-36.58%
2004-12-31NZ$0.71 B-12.59%
2003-12-31NZ$0.81 B-2.1%
2002-12-31NZ$0.83 B-22.89%
2001-12-31NZ$1.08 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$207.37 B 1,580.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$247.84 B 1,908.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$56.90 B 361.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$143.35 B 1,061.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$114.97 B 831.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
NZ$0.37 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA